Arcellx (ACLX)
(Real Time Quote from BATS)
$71.18 USD
-0.86 (-1.19%)
Updated Aug 6, 2025 10:00 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ACLX 71.18 -0.86(-1.19%)
Will ACLX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACLX
Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates
Arcellx, Inc. (ACLX) Reports Q4 Loss, Lags Revenue Estimates
ACLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?
5 Biotech Breakthrough Stocks to Watch in 2025
Other News for ACLX
Arcellx (ACLX) Price Target Boosted by Scotiabank
Arcellx price target raised by $40 at Scotiabank, here's why
4 Analysts Assess Arcellx: What You Need To Know
Scotiabank Raises Price Target for ACLX to $133 While Maintaining Sector Outperform Rating | ...
Bullish Two Hundred Day Moving Average Cross - ACLX